Delivery Order SPE2DB20D1004-SPE2DB25FNEJM
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,462.49, is for the supply of Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm-fixed-price structure and a completion date of September 24, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,444.28 firm fixed-price contract is for the delivery of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. This award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $7,264.63 and a completion date of September 5, 2024. There is no set-aside designation for this award. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $2,076.00 and covers the delivery of Glimepiride 4 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $1,025.72 and runs through November 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,303.06, is for the supply of Glimepiride 4 mg tablets to support military healthcare programs. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,660.70, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. The contract is not designated as a set-aside....
This $1,197.58 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,239,883 units of the prescription drug Glimepiride 4 mg tablets in 100-count bottles. The award has an ultimate completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a $1,248.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,712,661 tablets of the generic drug Glimepiride 4 mg. The contract has a final completion date of July 6, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...